Results 171 to 180 of about 98,325 (259)
Efficacy and safety of combining a thiazide diuretic with a loop diuretic in decompensated heart failure: A systematic review and meta-analysis. [PDF]
Bessa R +4 more
europepmc +1 more source
This review shows evidence from preclinical and clinical studies, supporting the therapeutic potential of polyphenols for diabetic kidney disease (DKD). This is due to their diverse bioactive properties and ability to intervene in intricate mechanisms of the disease.
Esienanwan E. Efiong +10 more
wiley +1 more source
Gastrin and D1 Dopamine Receptor Interact to Induce Natriuresis and Diuresis
Yue Chen +7 more
semanticscholar +1 more source
Retrospective Evaluation of Dosing Effects of Bumetanide Continuous Infusions in the Pediatric Cardiac Intensive Care Unit. [PDF]
Narasimhulu SS +13 more
europepmc +1 more source
ABSTRACT Background In elderly haemodialysis patients, poor functional status correlates with malnutrition, morbidity and mortality. This study aimed to assess 1‐year survival in an elderly haemodialysis population and evaluate the predictive capacity of commonly used scales for comorbidity, malnutrition, dependence and frailty.
M. L. Sanchez‐Tocino +10 more
wiley +1 more source
Pre-transplant residual diuresis and oxalic acid concentration influence kidney graft survival. [PDF]
Post Hospers G +17 more
europepmc +1 more source
Catalpol's potential in inhibiting cancer development and progression through various pathways. ABSTRACT Catalpol, a natural iridoid glycoside known for its anti‐proliferative effects, has been proposed as an anticancer compound. Catalpol targets critical processes involved in cancer cell progression, like malignant proliferation, apoptosis, and ...
Lucas Fornari Laurindo +13 more
wiley +1 more source
A Population Pharmacokinetic Analysis for Piperacillin/Tazobactam in Patients with End-Stage Kidney Disease Undergoing Intermittent Haemodialysis: Extension of a General-Purpose Model. [PDF]
Kong D +6 more
europepmc +1 more source
Clinical applications of urinary sodium in heart failure from prognostic marker to clinical tool
ESC Heart Failure, Volume 12, Issue 5, Page 3209-3211, October 2025.
Jeroen Dauw
wiley +1 more source
Abstract Aims Sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are effective antihyperglycaemic agents; however, they also increase the risk of diabetic ketoacidosis (DKA). As the clinical evidence comparing DKA features between SGLT2i users and non‐users remains limited due to the low incidence of DKA, this study aimed to compare the clinical ...
Dahyeon Lee +4 more
wiley +1 more source

